These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 23410688)

  • 1. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human papilloma virus genotyping assay using restriction fragment mass polymorphism analysis, and its comparison with sequencing and hybrid capture assays].
    Lee EH; Chung HJ; Oh HB; Chi HS; Jee MS; Park SN; Hong SP; Yoo W; Kim SO
    Korean J Lab Med; 2007 Feb; 27(1):62-8. PubMed ID: 18094553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and identification of human papillomavirus using a PCR-restriction fragment mass polymorphism assay.
    Lee JK; Hong YJ; Um TH; Lee EH; Chi HS; Koh JS; Yim HW; Cha YJ
    Mol Med Rep; 2011; 4(4):645-50. PubMed ID: 21503578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.
    van Hamont D; van Ham MA; Bakkers JM; Massuger LF; Melchers WJ
    J Clin Microbiol; 2006 Sep; 44(9):3122-9. PubMed ID: 16954236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HPV genotyping assays and Hybrid Capture 2 for detection of high-risk HPV in cervical specimens.
    Um TH; Lee EH; Chi HS; Kim JW; Hong YJ; Cha YJ
    Ann Clin Lab Sci; 2011; 41(1):48-55. PubMed ID: 21325255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses.
    Lee HP; Kim SO; Hwang TS; Bae JM; Kim SN; Kim JW; Hwang SY; Lee HS; Shin SK; Cho W; Hong SP
    J Med Virol; 2011 Mar; 83(3):471-82. PubMed ID: 21264868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
    Stevens MP; Garland SM; Rudland E; Tan J; Quinn MA; Tabrizi SN
    J Clin Microbiol; 2007 Jul; 45(7):2130-7. PubMed ID: 17494721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens.
    Yoon YA; Kim BH; Heo SH; Kim HJ; Choi YJ
    Arch Virol; 2018 Apr; 163(4):969-976. PubMed ID: 29327232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
    Yu S; Kwon MJ; Lee EH; Park H; Woo HY
    J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland.
    Dobec M; Bannwart F; Kaeppeli F; Cassinotti P
    J Clin Virol; 2009 May; 45(1):23-7. PubMed ID: 19375383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
    Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two commercially available methods for HPV genotyping: CLART HPV2 and Linear Array HPV Genotyping tests.
    Chranioti A; Spathis A; Aga E; Meristoudis C; Pappas A; Panayiotides I; Karakitsos P
    Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):257-63. PubMed ID: 23301385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
    Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
    J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection.
    Ko K; Kwon MJ; Lee EH; Woo HY; Park H
    J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27387091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.